reviewArthritis Research & TherapyJan 1, 2007GOLD OA

Biology of RANK, RANKL, and osteoprotegerin

University of Rochester Medical Center

PubMed
Indexed incrossrefdoajpubmed

Abstract

The discovery of the receptor activator of nuclear factor-kappaB ligand (RANKL)/RANK/osteoprotegerin (OPG) system and its role in the regulation of bone resorption exemplifies how both serendipity and a logic-based approach can identify factors that regulate cell function. Before this discovery in the mid to late 1990s, it had long been recognized that osteoclast formation was regulated by factors expressed by osteoblast/stromal cells, but it had not been anticipated that members of the tumor necrosis factor superfamily of ligands and receptors would be involved or that the factors involved would have extensive functions beyond bone remodeling. RANKL/RANK signaling regulates the formation of multinucleated…

Citation impact

946
total citations
FWCI
12.51
Percentile
100%
References
47
Citations per year

Authors

2

Topics & keywords

Keywords
  • RANKL
  • Osteoprotegerin
  • Osteoclast
  • RANK Ligand
  • Bone resorption
  • Bone remodeling
  • Stromal cell
  • Osteoblast
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding